Nyrada (ASX:NYR)
ASX announcement history & article coverage
Transparent by design.
Announcments by Nyrada (ASX:NYR) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
PROTECT-MI Phase IIa Clinical Trial Update No 2
Notification of cessation of securities - NYR
Cleansing Statement
Application for quotation of securities - NYR
Cleansing Statement
Application for quotation of securities - NYR
Cleansing Statement
Application for quotation of securities - NYR
Change of Director's Interest Notice - JB
PROTECT-MI Phase IIa Clinical Trial Update
Investor Presentation
Nyrada Successfully Completes Cardioprotection Pilot Study
Nyrada Receives A$2.455M R&D Tax Incentive Rebate
Cleansing Statement
Application for quotation of securities - NYR
Upcoming Expiry of Unlisted Options
Xolatryp Enhances Anthracycline Anti-Tumour Efficacy
Trading Halt
Pause in Trading
Nyrada Inc. trading halt announced pending further update
Nyrada Receives Notice of Allowance for Xolatryp US Patent
Nyrada Granted US Patent Allowance for Xolatryp® Drug Candidate
First Site Activated in Nyradas PROTECT-MI Phase IIa Trial
Quarterly Activities Report and Appendix 4C
Nyrada gains ethics approval for Phase IIa Xolatryp trial, reports AU$6.74M cash and AU$2.45M R&D rebate expected
